EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C51H34N6O23S6.6Na |
| Net Charge | 0 |
| Average Mass | 1429.194 |
| Monoisotopic Mass | 1427.93857 |
| SMILES | Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)[O-])c5cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c45)ccc3C)c2)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] |
| InChI | InChI=1S/C51H40N6O23S6.6Na/c1-25-9-11-29(49(60)54-37-13-15-41(83(69,70)71)35-21-33(81(63,64)65)23-43(45(35)37)85(75,76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72,73)74)36-22-34(82(66,67)68)24-44(46(36)38)86(78,79)80;;;;;;/h3-24H,1-2H3,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80);;;;;;/q;6*+1/p-6 |
| InChIKey | VAPNKLKDKUDFHK-UHFFFAOYSA-H |
| Roles Classification |
|---|
| Biological Roles: | purinergic receptor P2 antagonist An antagonist at purinergic P2 receptors GABA antagonist A compound that inhibits the action of γ-aminobutyric acid. EC 2.7.11.13 (protein kinase C) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of protein kinase C (EC 2.7.11.13). antileishmanial agent An antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania. apoptosis inhibitor Any substance that inhibits the process of apoptosis (programmed cell death) in multi-celled organisms. trypanocidal drug A drug used to treat or prevent infections caused by protozoal organisms belonging to the suborder Trypanosomatida. ryanodine receptor agonist A ryanodine receptor modulator which activates the receptor. Ryanodine receptors (RyRs) act as selective ion channels, modulating the release of calcium. Activating the receptors causes the release of calcium, so depleting internal calcium and ultimately preventing further muscle contraction. |
| Applications: | GABA antagonist A compound that inhibits the action of γ-aminobutyric acid. angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. antinematodal drug A substance used in the treatment or control of nematode infestations. antileishmanial agent An antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. trypanocidal drug A drug used to treat or prevent infections caused by protozoal organisms belonging to the suborder Trypanosomatida. renoprotective agent Any compound that is able to prevent damage to the kidneys. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| suramin sodium (CHEBI:9364) has part suramin(6−) (CHEBI:180911) |
| suramin sodium (CHEBI:9364) has role angiogenesis inhibitor (CHEBI:48422) |
| suramin sodium (CHEBI:9364) has role antileishmanial agent (CHEBI:70868) |
| suramin sodium (CHEBI:9364) has role antinematodal drug (CHEBI:35444) |
| suramin sodium (CHEBI:9364) has role antineoplastic agent (CHEBI:35610) |
| suramin sodium (CHEBI:9364) has role apoptosis inhibitor (CHEBI:68494) |
| suramin sodium (CHEBI:9364) has role EC 2.7.11.13 (protein kinase C) inhibitor (CHEBI:37700) |
| suramin sodium (CHEBI:9364) has role GABA antagonist (CHEBI:65259) |
| suramin sodium (CHEBI:9364) has role GABA-gated chloride channel antagonist (CHEBI:38999) |
| suramin sodium (CHEBI:9364) has role purinergic receptor P2 antagonist (CHEBI:91079) |
| suramin sodium (CHEBI:9364) has role renoprotective agent (CHEBI:231911) |
| suramin sodium (CHEBI:9364) has role ryanodine receptor agonist (CHEBI:67114) |
| suramin sodium (CHEBI:9364) has role trypanocidal drug (CHEBI:36335) |
| suramin sodium (CHEBI:9364) is a organic sodium salt (CHEBI:38700) |
| IUPAC Name |
|---|
| hexasodium 8,8'-{carbonylbis[iminobenzene-3,1-diylcarbonylimino(4-methylbenzene-3,1-diyl)carbonylimino]}dinaphthalene-1,3,5-trisulfonate |
| INNs | Source |
|---|---|
| suramina de sodio | WHO MedNet |
| suramine sodique | WHO MedNet |
| suramin sodium | WHO MedNet |
| suraminum natricum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 8,8'-[ureylenebis[m-phenylene carbonylimino(4-methyl-m-phenylene)carbonylimino]]di(1,3,5-naphthalenetrisulfonic acid) hexasodium salt | ChEBI |
| BAY 205 | ChemIDplus |
| BAY-205 | ChEMBL |
| BAYER-205 | ChEMBL |
| CI 1003 | ChemIDplus |
| CI-1003 | ChemIDplus |
| Brand Names | Source |
|---|---|
| Antrypol | ChemIDplus |
| Bayer 205 | KEGG DRUG |
| Fourneau 309 | ChemIDplus |
| Germanin | ChemIDplus |
| Moranyl | ChemIDplus |
| Naganin | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| 5167 | ChemSpider |
| D00808 | KEGG DRUG |
| DBSALT000540 | DrugBank |
| US4737521 | Patent |
| Registry Numbers | Sources |
|---|---|
| CAS:129-46-4 | ChemIDplus |
| Citations |
|---|